A LOW DOSE GLUCOCORTICOID, LOW DOSE CYCLOPHOSPHAMIDE, RITUXIMAB TREATMENT PROTOCOL AS INDUCTION THERAPY IN ANCA ASSOCIATED VASCULITIS PATIENTS

被引：0
|
作者：
Spanos, Georgios [1 ]
Paschou, Styliani [1 ]
Bakou, Marianna [1 ]
Atalla, Alexandros [1 ]
Bantis, Christos [1 ]
Fragidis, Stylianos [1 ]
Armetzoiou, Livia Karmen [1 ]
Bamichas, Gerasimos [1 ]
机构：
[1] Gen Hosp Thessaloniki G Papanikolaou, Dept Nephrol, Thessaloniki, Greece
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
5835
引用
收藏
页码：I405 / I406
页数：2
相关论文
共 50 条
  • [41] Incidence of Pneumocystis Jiroveci Pneumonia in Patients With ANCA-Associated Vasculitis Initiating Therapy With Rituximab or Cyclophosphamide
    Nettleton, Elizabeth
    Sattui, Sebastian E.
    Wallace, Zachary
    Putman, Michael
    ARTHRITIS CARE & RESEARCH, 2024, 76 (02) : 288 - 294
  • [42] Safety of Methotrexate and Low-Dose Trimethoprim-Sulfamethoxazole in Patients with ANCA-Associated Vasculitis
    Tamaki, Hiromichi
    Butler, Robert
    Langford, Carol A.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [43] Safety of remission induction with rituximab versus cyclophosphamide in patients 65 and older with severe ANCA-associated vasculitis
    Miloslavsky, E.
    Specks, U.
    Merkel, P.
    Seo, P.
    Spiera, R.
    Langford, C.
    Hoffman, G.
    Kallenberg, C.
    St Clair, W.
    Tchao, N.
    Ding, L.
    Ikle, D.
    Jepson, B.
    Brunetta, P.
    Stone, J.
    PRESSE MEDICALE, 2013, 42 (04): : 779 - 780
  • [44] Rituximab for remission induction in elderly patients with ANCA-associated vasculitis
    Timlin, H.
    Lee, S. M.
    Manno, R. L.
    Seo, P.
    Geetha, Duvura
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (01) : 67 - 69
  • [45] Avacopan in ANCA-associated Vasculitis Received Intensified Induction Therapy with Cyclophosphamide Plus Rituximab - Retrospective Case Serial of 12 Patients
    Assmann, Gunter
    Rittich, Christoph
    Neumann, Frank
    Kellner, Udo
    Turkiewicz, Ryszard
    Radermacher, Joerg
    Lamprecht, Peter
    Tampe, Bjoern
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1361 - 1362
  • [46] The timing of low dose glucocorticoid therapy in treatment of rheumatoid arthritis
    Karatay, S
    Senel, K
    Ugur, M
    Yildirim, K
    PAIN CLINIC, 2002, 13 (04): : 305 - 312
  • [47] Is Rituximab Superior to Cyclophosphamide for ANCA-Associated Vasculitis for Induction of Remission, and with a Better Safety Profile?
    Ignacio Garcia-Valladares
    Luis R. Espinoza
    Current Rheumatology Reports, 2010, 12 (6) : 395 - 398
  • [48] Long term follow up of patients who received repeat dose rituximab as maintenance therapy for ANCA associated vasculitis (AAV)
    Smith, R.
    Alberici, F.
    Jones, R.
    Jayne, D.
    PRESSE MEDICALE, 2013, 42 (04): : 775 - 776
  • [49] LONG TERM FOLLOW UP OF PATIENTS WHO RECEIVED REPEAT DOSE RITUXIMAB AS MAINTENANCE THERAPY FOR ANCA ASSOCIATED VASCULITIS (AAV)
    Alberici, Federico
    Smith, Rona
    Jones, Rachel
    Jayne, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 2 - 2
  • [50] Evaluation of low-dose glucocorticoid regimen in association with cyclophosphamide in patients with glomerulonephritis
    Hirja, Anca Roxana
    Voroneanu, Luminita
    Siriopol, Dimitrie
    Nistor, Ionut
    Hogas, Simona
    Apetrii, Mugurel
    Volovat, Carmen
    Veisa, Gabriel
    Mititiuc, Irina Luanda
    Florea, Laura
    Onofriescu, Mihai
    Covic, Adrian
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2019, 51 (10) : 1805 - 1813
12345